AMBER TEETHING NECKLACE SALES BUSINESS PLAN

I. Executive Summary

Company Description

The company name references the product origin and tradition of Baltic amber and signals natural, heritage-based teething care. We operate in the U.S. e-commerce sector as a direct-to-consumer seller of authentic Baltic amber teething solutions. Our core products are necklaces and complementary infant-safe accessories sourced from certified artisans and verified through U.S. laboratory testing to ensure safety and lab-verified authenticity. The business is headquartered in a major U.S. tech hub and organized as a lean, scalable team focused on sourcing, quality assurance, online merchandising, and fulfillment. Founded for a 2026 launch.

What sets us apart is the combination of documented lab testing, artisan certification, and modern aesthetic design tailored for contemporary parents seeking natural, holistic teething relief. Day-to-day activities include supplier audits, lab coordination, product photography and e-commerce operations, customer support, and targeted digital marketing. We target new and expectant parents in the U.S. who prioritize natural remedies and product safety. Short-term goal: execute a compliant 2026 market launch and establish a verified online presence; long-term goal: become the leading trusted brand for parents seeking natural teething relief.

Problem

Infant teething causes measurable symptoms: irritability and severe sleep disruption for many U.S. parents, increasing household stress and care burden. Health-conscious parents seek non-pharmacological teething relief but face limited access to certified, natural options that are both safe for infants and visually acceptable at home.

Current solutions are underserved: over-the-counter medications are often avoided, and the market lacks widely available products that combine verified safety testing, lab-verified authenticity, and modern design. This gap creates demand for a trusted, tested, natural teething option sold direct-to-consumer in the U.S.

Solution

New parents need a reliable, safety-tested natural option for infant teething relief because uncertified, potentially unsafe teething aids are common and teething disrupts sleep and family well-being.

We offer a curated collection of handcrafted Baltic amber teething necklaces that provide a natural, drug-free soothing option; each uses lab-verified genuine Baltic amber, includes individual knots between beads and specialized safety-release clasps, and features minimalist designs to serve as a trustworthy, safety-focused alternative for caregivers.

Mission Statement

Our mission is to provide parents with peace of mind through safe, authentic, natural teething solutions that support holistic infant wellness and avoid harsh chemicals.

We are dedicated to transparency, safety, and the preservation of traditional homeopathic practices through modern verification, delivering products that are as beautiful as they are functional.

We strive to build a supportive community for health-conscious families and to be the most trusted name in natural parenting, one lab-certified necklace at a time.

Key Success Factors

Success hinges on trust, low acquisition cost, repeat buyers, targeted marketing, and strong margins.

• Independent third-party lab testing that establishes consumer trust and brand authority.
• Low CAC declining to $12 by 2030 to enable scalable e-commerce growth.
• 15% repeat customer rate to increase customer lifetime value and profitability.
• Influencer and content marketing focused on digitally-native parents to drive acquisition.
• Maintained gross margin through optimized sourcing and premium pricing to hit $427,000 EBITDA in Year 5.

Financial Summary

The five-year plan projects scaled online retail growth from $134,000 in 2026 to $1,263,000 in 2030, with breakeven in January 2029.

Financial requirements: marketing spend rises from $50,000 (2026) to $250,000 (2030); maintain a minimum cash cushion of $549,000 (min cash month: Jan-29). Anticipated overall return: ROE 17% by Year 5 and IRR ~54% (plan-level).

Outlook: profitable scale targeted with positive EBITDA of $427,000 and sustained cash runway by 2030.

Funding Requirements

We seek $1,085,500 to fund product development, inventory, staffing, scaled marketing, operating losses through 2028, and a minimum cash reserve to execute the five-year growth plan.

Projected revenue grows from $134,000 in 2026 to $1,263,000 in 2030, breakeven arrives January 1, 2029, Year‑5 EBITDA is $427,000, and minimum cash is held at $549,000.